Advertisement
Canada markets close in 2 hours 17 minutes

  • S&P/TSX

    21,876.68
    +2.96 (+0.01%)
     

  • S&P 500

    5,042.89
    -28.74 (-0.57%)
     

  • DOW

    38,096.84
    -364.08 (-0.95%)
     

  • CAD/USD

    0.7317
    +0.0019 (+0.26%)
     

  • CRUDE OIL

    82.85
    +0.04 (+0.05%)
     

  • Bitcoin CAD

    88,286.30
    -566.13 (-0.64%)
     

  • CMC Crypto 200

    1,391.14
    +8.57 (+0.62%)
     

  • GOLD FUTURES

    2,343.20
    +4.80 (+0.21%)
     

  • RUSSELL 2000

    1,971.91
    -23.52 (-1.18%)
     

  • 10-Yr Bond

    4.7040
    +0.0520 (+1.12%)
     

  • NASDAQ

    15,578.50
    -134.25 (-0.85%)
     

  • VOLATILITY

    16.42
    +0.45 (+2.82%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6812
    -0.0007 (-0.10%)
     
MARKETS LIVE BLOG:

STOCKS SLIDE AFTER META'S REALITY CHECK, DOWNBEAT GDP

Caterpillar sinks 7% after earnings, management sees weakness in Europe, Asia-Pacific

Today's Research Reports on Aurinia Pharmaceuticals, Canopy Growth, Sernova and Microbix Biosystems

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / August 28, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI Initiates Coverage on:

Aurinia Pharmaceuticals Inc.
https://rdinvesting.com/news/?ticker=AUP.TO

Canopy Growth Corporation
https://rdinvesting.com/news/?ticker=WEED.TO

Sernova Corp.
https://rdinvesting.com/news/?ticker=SVA.V

Microbix Biosystems Inc.
https://rdinvesting.com/news/?ticker=MBX.TO

ADVERTISEMENT

Aurinia Pharmaceuticals' stock moved 1.28% higher Monday, to close the day at $7.13. The stock recorded a trading volume of 13,302 shares, which was below its three months average volume of 25,614 shares. In the last year, Aurinia Pharmaceuticals' shares have traded in a range of 5.68 - 9.50. The share price has gained 25.53% from its 52 week low. The company's shares are currently trading at their 200-day moving average. The stock's 50-day moving average of $7.32 is greater than its 200-day moving average of $7.13. Shares of Aurinia Pharmaceuticals have gained approximately 24.65 percent year-to-date.

Access RDI's Aurinia Pharmaceuticals Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AUP.TO

On Monday, shares of Canopy Growth recorded a trading volume of 12,584,930 shares, which was above the three months average volume of 5,857,046 shares. The stock ended the day 2.35% higher at 60.00. The share price has gained 584.15% from its 52-week low with a 52-week trading range of 8.77 - 62.79. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $38.34 is greater than its 200-day moving average of $34.34. Shares of Canopy Growth have gained approximately 101.75 percent year-to-date.

Access RDI's Canopy Growth Corporation Research Report at:
https://rdinvesting.com/news/?ticker=WEED.TO

Sernova's stock moved 2.27% higher Monday, to close the day at $0.23. The stock recorded a trading volume of 151,842 shares, which was below its three months average volume of 194,447 shares. In the last year, Sernova's shares have traded in a range of 0.18 - 0.51. The share price has gained 25.00% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.22 is below its 200-day moving average of $0.30. Shares of Sernova have fallen approximately 45.24 percent year-to-date.

Access RDI's Sernova Corp. Research Report at:
https://rdinvesting.com/news/?ticker=SVA.V

On Monday, shares of Microbix Biosystems recorded a trading volume of 10,500 shares, which was below the three months average volume of 42,753 shares. The stock ended the day 3.85% higher at 0.27. The share price has gained 22.73% from its 52-week low with a 52-week trading range of 0.22 - 0.40. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.26 is below its 200-day moving average of $0.28. Shares of Microbix Biosystems have fallen approximately 12.9 percent year-to-date.

Access RDI's Microbix Biosystems Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MBX.TO

Our Actionable Research on Aurinia Pharmaceuticals Inc. (TSX:AUP.TO) and Canopy Growth Corporation (TSX:WEED.TO) and Sernova Corp. (TSXV:SVA.V) and Microbix Biosystems Inc. (TSX:MBX.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com